TRIL - A sleeping giant!

NASDAQ:TRIL   Trillium Therapeutics Inc
After an amazing 2020, I expect the distribution phase to last throughout 2021. TRIL's last update stated the following:
  • Trillium expects a robust flow of new data updates and multiple catalysts in 2022.
  • As of March 31, 2021, Trillium had $276 million in cash, cash equivalents, and marketable securities, sufficient to fund operations into 2023.

Next stop for TRIL could be the 200 MA on the one week timeframe at around 6.00, but don't be surprised if the price is pushed down further as more weak hands bail on TRIL . TRIL is clearly stating it won't have any real updates and catalysts until 2022, so I'll be looking to accumulate later this year. I prefer the channel to form between the 2.50 and 3.50 price range, which will be dirt cheap for this potential monster. GL